MARKET

RDY

RDY

Dr Reddys Labs
NYSE
13.60
+0.05
+0.37%
After Hours: 13.49 -0.11 -0.81% 17:56 05/22 EDT
OPEN
13.55
PREV CLOSE
13.55
HIGH
13.61
LOW
13.48
VOLUME
723.65K
TURNOVER
--
52 WEEK HIGH
16.17
52 WEEK LOW
12.19
MARKET CAP
11.32B
P/E (TTM)
24.72
1D
5D
1M
3M
1Y
5Y
1D
Hims & Hers launches generics for Novo’s semaglutide in Canada
Seeking Alpha · 3d ago
Dr. Reddy’s Files Form 6-K and Publishes FY26 Earnings Call Transcript
TipRanks · 5d ago
Dr. Reddy’s Schedules Global Investor Meetings for Late May–Early June 2026
TipRanks · 6d ago
Weekly Report: what happened at RDY last week (0511-0515)?
Weekly Report · 6d ago
Reported Saturday, Dr. Reddy's Breaks Ground As First Generic Semaglutide Injection Launcher In Canada, Expanding Global GLP-1 Therapy Access
Benzinga · 6d ago
Dr. Reddy’s launches generic Semaglutide injection in Canada
TipRanks · 6d ago
Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push
Benzinga · 05/16 19:17
DR. REDDY'S LABORATORIES LAUNCHES ITS GENERIC SEMAGLUTIDE INJECTION IN CANADA
Reuters · 05/16 07:18
More
About RDY
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Webull offers Dr Reddy's Laboratories Ltd (ADR) stock information, including NYSE: RDY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDY stock methods without spending real money on the virtual paper trading platform.